We are live on ! Find out more
LS

Leelyn Smith Portfolio holdings

AUM $822M Turnover 11.52%
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$23.3M
Cap. Flow
+$15.2M
Cap. Flow %
4.53%
Top 10 Hldgs %
40.79%
Holding
397
New
32
Increased
145
Reduced
77
Closed
9
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1 year

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.04%
2 Technology 10.61%
3 Healthcare 7.68%
4 Consumer Discretionary 7.22%
5 Financials 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BYND icon
301
Beyond Meat
BYND
$123M
$8K ﹤0.01%
2
– –
2019 Q4
5 quarters
DNP icon
302
DNP Select Income Fund
DNP
$3.72B
$8K ﹤0.01%
827
– –
2019 Q4
5 quarters
FXL icon
303
First Trust Technology AlphaDEX Fund
FXL
$2.82B
$8K ﹤0.01%
69
– –
2019 Q4
5 quarters
IRM icon
304
Iron Mountain
IRM
$33.5B
$8K ﹤0.01%
224
– –
2019 Q4
5 quarters
IWO icon
305
iShares Russell 2000 Growth ETF
IWO
$13.7B
$8K ﹤0.01%
27
– –
2020 Q4
1 quarter
LUV icon
306
Southwest Airlines
LUV
$20B
$8K ﹤0.01%
125
+2
+2% +$106
2020 Q2
3 quarters
QTEC icon
307
First Trust NASDAQ-100 Technology Index Fund
QTEC
$3.83B
$8K ﹤0.01%
53
– –
2019 Q4
5 quarters
TT icon
308
Trane Technologies
TT
$101B
$8K ﹤0.01%
50
-50
-50% -$7.74K
2020 Q4
1 quarter
CI icon
309
Cigna
CI
$79B
$7K ﹤0.01%
30
– –
2019 Q4
5 quarters
CMS icon
310
CMS Energy
CMS
$21B
$7K ﹤0.01%
120
-445
-79% -$25.6K
2020 Q1
4 quarters
CSX icon
311
CSX Corp
CSX
$90.2B
$7K ﹤0.01%
204
– –
2019 Q4
5 quarters
FNY icon
312
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$562M
$7K ﹤0.01%
110
– –
2019 Q4
5 quarters
IWV icon
313
iShares Russell 3000 ETF
IWV
$20.4B
$7K ﹤0.01%
28
– –
2019 Q4
5 quarters
KSS icon
314
Kohl's
KSS
$2.54B
$7K ﹤0.01%
121
+2
+2% +$103
2020 Q2
3 quarters
SCHP icon
315
Schwab US TIPS ETF
SCHP
$16.3B
$7K ﹤0.01%
240
+2
+0.8% +$62
2020 Q3
2 quarters
SCZ icon
316
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.7B
$7K ﹤0.01%
95
– –
2020 Q4
1 quarter
TDOC icon
317
Teladoc Health
TDOC
$1.08B
$7K ﹤0.01%
41
– –
2020 Q4
1 quarter
WDAY icon
318
Workday
WDAY
$47.4B
$7K ﹤0.01%
30
– –
2019 Q4
5 quarters
GE icon
319
GE Aerospace
GE
$324B
$6K ﹤0.01%
99
+5
+5% +$303
2020 Q4
1 quarter
IGLB icon
320
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.69B
$6K ﹤0.01%
83
+25
+43% +$1.72K
2019 Q4
5 quarters
NEM icon
321
Newmont
NEM
$122B
$6K ﹤0.01%
100
– –
2020 Q4
1 quarter
NTR icon
322
Nutrien
NTR
$33.2B
$6K ﹤0.01%
120
– –
2020 Q4
1 quarter
TIP icon
323
iShares TIPS Bond ETF
TIP
$14.4B
$6K ﹤0.01%
46
+22
+92% +$2.79K
2019 Q4
5 quarters
WORK
324
DELISTED
Slack Technologies, Inc.
WORK
$6K ﹤0.01%
137
– –
2020 Q1
4 quarters
CHTR icon
325
Charter Communications
CHTR
$12.6B
$5K ﹤0.01%
8
– –
2020 Q4
1 quarter

Similar funds

Leelyn Smith's Q1 2021 Portfolio in Review

As of Q1 2021, Leelyn Smith held 397 positions worth $336M, up 7.4% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Leelyn Smith deployed $15.2M of net new capital in Q1 2021, opening 32 new positions and adding to 145 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $2.01M trimmed.

  • Leelyn Smith's largest Q1 2021 buy was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
  • Leelyn Smith added most to Invesco QQQ Trust in Q1 2021, an estimated $2.55M increase.
  • Leelyn Smith's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $2.01M.
  • Leelyn Smith fully exited Colgate-Palmolive in Q1 2021, selling an estimated $94K.
  • Leelyn Smith's ten largest holdings make up 41% of its $336M portfolio in Q1 2021.
  • Leelyn Smith opened 32 new positions and closed 9 in Q1 2021.
  • Leelyn Smith's portfolio value rose 7.4% quarter-over-quarter to $336M.

Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.